{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:17:20Z","timestamp":1778055440736,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Research Council of Lillebaelt Hospital"},{"DOI":"10.13039\/100008363","name":"The Danish Cancer Society","doi-asserted-by":"crossref","award":["00 262 120"],"award-info":[{"award-number":["00 262 120"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1136\/ijgc-2020-001528","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T05:35:12Z","timestamp":1593063312000},"page":"1444-1449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Use of PROM during follow-up of patients with ovarian cancer: the PROMova study protocol"],"prefix":"10.1016","volume":"30","clinical-trial-number":[{"clinical-trial-number":"nct02916875","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Anette Stolberg","family":"Kargo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Coulter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Lindemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pernille Tine","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels Henrik","family":"Hj\u00f8llund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berit Jul","family":"Mosgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina Dahl","family":"Steffensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2020-001528_bb0010","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/annonc\/mdz062","article-title":"ESMO\u2013ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","volume":"30","author":"Colombo","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2020-001528_bb0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejogrb.2017.04.016","article-title":"British Gynaecological Cancer Society (BGCS) epithelial ovarian\/fallopian tube\/primary peritoneal cancer guidelines: recommendations for practice","volume":"213","author":"Fotopoulou","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1136\/ijgc-2020-001528_bb0020","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3747\/co.23.3042","article-title":"Follow-up of patients who are clinically disease-free after primary treatment for fallopian tube, primary peritoneal, or epithelial ovarian cancer: a program in evidence-based care guideline adaptation","volume":"23","author":"Le","year":"2016","journal-title":"Curr Oncol"},{"key":"10.1136\/ijgc-2020-001528_bb0025","unstructured":"Sundhedsstyrelsen . Opf\u00f8lgningsprogram for gyn\u00e6kologiske kr\u00e6ftformer. Available: https:\/\/sundhedsstyrelsen.dk\/da\/udgivelser\/2015\/~\/media\/7A5551B622F74EF79392E20495AFF608.ashx [Accessed 15 Feb 2016]."},{"key":"10.1136\/ijgc-2020-001528_bb0030","author":"Kr\u00e6ftens Bek\u00e6mpelse","year":"2019","journal-title":"Kr\u00e6ftpatienters behov og oplevelser med sundhedsv\u00e6senet i opf\u00f8lgnings- og efterforl\u00f8bet, Kr\u00e6ftens Bek\u00e6mpelse Barometerunders\u00f8gelsen"},{"key":"10.1136\/ijgc-2020-001528_bb0035","unstructured":"Cancer PROMs for Macmillan cancer support . Available: https:\/\/www.academia.edu\/22582678\/Cancer_PROMs_a_scoping_study [Accessed 5 Oct 2016]."},{"key":"10.1136\/ijgc-2020-001528_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010299","article-title":"Patient-reported outcome measures for follow-up after gynaecological cancer treatment","author":"Nama","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1136\/ijgc-2020-001528_bb0045","doi-asserted-by":"crossref","first-page":"e15856","DOI":"10.2196\/15856","article-title":"Fifteen years' use of patient-reported outcome measures at the group and patient levels: trend analysis","volume":"21","author":"Hjollund","year":"2019","journal-title":"J Med Internet Res"},{"key":"10.1136\/ijgc-2020-001528_bb0050","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-2020-001528_bb0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0959-8049(00)00369-5","article-title":"Development of a European Organization for Research and Treatment of Cancer questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report","volume":"37","author":"Cull","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2020-001528_bb0060","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pec.2013.05.009","article-title":"Developing collaborate: a fast and frugal patient-reported measure of shared decision making in clinical encounters","volume":"93","author":"Elwyn","year":"2013","journal-title":"Patient Educ Couns"},{"key":"10.1136\/ijgc-2020-001528_bb0065","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/fampra\/18.4.410","article-title":"A new, brief questionnaire (PEQ) developed in primary health care for measuring patients' experience of interaction, emotion and consultation outcome","volume":"18","author":"Steine","year":"2001","journal-title":"Fam Pract"},{"key":"10.1136\/ijgc-2020-001528_bb0070","unstructured":"Danish Health Authority . Pakkeforl\u00f8b for kr\u00e6ft i \u00e6ggestokkene. Available: https:\/\/www.sst.dk\/da\/udgivelser\/2019\/pakkeforloeb-for-kraeft-i-aeggestokkene"},{"key":"10.1136\/ijgc-2020-001528_bb0075","unstructured":"Sundhedsstyrelsen . Kontrolforl\u00f8b for gyn\u00e6kologiske kr\u00e6ftpatienter \u2013 en medicinsk teknologiskvurdering. Available: https:\/\/www.sst.dk\/-\/media\/Udgivelser\/2009\/Publ2009\/MTV\/Ktrlforl_gynaek_kraeftpat\/MTV_kontrolforloeb_net_final_ver_2,-d-,pdf.ashx [Accessed 24 Apr 2020]."},{"key":"10.1136\/ijgc-2020-001528_bb0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.2017.7156","article-title":"Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment","volume":"318","author":"Basch","year":"2017","journal-title":"JAMA"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24006716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24006716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2020-001528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:39:20Z","timestamp":1753223960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24006716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1048891X24006716"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2020-001528","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of PROM during follow-up of patients with ovarian cancer: the PROMova study protocol","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2020-001528","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}